| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP, Finance And Accounting
1 company
Ogden Christopher is a Chief Financial Officer at CytomX Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $905K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 12,255 | $2.72 | $33,381.43 | -2.8% | -19.1% | - | |
| Mar 18, 2025 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 8,551 | $0.60 | $5,122.05 | -4.1% | +307.5% | +628.8% | |
| Aug 20, 2024 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,984 | $1.23 | $2,438.53 | -1.8% | -30.4% | +58.9% | |
| Mar 19, 2024 | CTMX Cytomx Therapeutics, Inc. | SVP, Finance And Accounting | Sell | 2,971 | $2.09 | $6,196.02 | -3.4% | -37.2% | -69.3% | |
| Dec 20, 2023 | CTMX Cytomx Therapeutics, Inc. | SVP, Finance And Accounting | Sell | 1,990 | $1.38 | $2,747.39 | -3.9% | +62.7% | -17.9% | |
| Mar 16, 2023 | CTMX Cytomx Therapeutics, Inc. | SVP, Finance And Accounting | Sell | 516 | $1.98 | $1,021.32 | -1.3% | -19.1% | +6.7% |